Professor Adam Frampton is a consultant general and hepato-pancreato-biliary surgeon in Surrey and London. He is skilled in treating complex gallstone disease (cholecystectomy), and performing groin and abdominal wall hernia repair, and specialises in liver, pancreatic, and biliary surgery. He has a specialist interest in investigating and treating all benign and cancerous disorders of the liver, pancreas, and biliary-tract. After qualifying from Imperial College London in 2003, he went on to gain an MSc in General Surgical Practice from the University of Kent in 2011, before returning to Imperial College London, where he was awarded a PhD in 2014 for his work on complex gene interactions in pancreatic cancer. He underwent basic and higher surgical training in London and Surrey, and became a fellow of the Royal College of Surgeons of England in 2018. During his training he undertook several international observerships in both the USA and Europe, and has gained exceptional experience in his field. Professor Frampton is extremely passionate about research, and aims to translate new discoveries directly into improved patient care. He is one of the most knowledgeable specialists in his field and has won numerous awards for his research including the Moynihan prize, the Sir James Fraser Travelling Fellowship and the Hunterian Professorship. He is currently tenured Assoc. Professor in Surgical Oncology and Head of Oncology at the University of Surrey where he leads a laboratory group and supervises BSc, MSc, MD and PhD students. His current research includes investigating the molecular aspects of pancreatic, liver and biliary-tract cancers, including the development of clinically useful biomarkers and targeted anti-cancer treatments, and understanding the tumour microenvironment and mechanisms of metastasis (cancer spread), topics on which he regularly publishes his findings in peer-reviewed journals. Professor Frampton’s research is at the “cutting-edge” and consequently he offers a highly analytical and evidence-based approach for his patients.

Pancreatitis Laparoscopy Gallstones Hernia Liver surgery Pancreas surgery

FRCS (Gen Surg), Fellow of Royal College of Surgeons England (2018) ?Hunterian Professorship, Royal College of Surgeons England (2018) FRSB, Royal Society of Biology (2017) ?PhD, Molecular oncology, Imperial College London (2014) ?MSc (Merit), General Surgical Practice, University of Kent (2011) ?MRCSEd, Member of Royal College of Surgeons Edinburgh (2009) ?MB BS, Imperial College London School of Medicine (2003) ?BSc (Hons), Pharmacology and Toxicology, Im

Association of Upper GI Surgeons (AUGIS) Royal Society for Biology (RSB) Society for Surgery of the Alimentary Tract (SSAT), USA British Association of Surgical Oncologists (BASO) European Pancreatic Club (EPC) & Pancreatic Society The Association of Surgeons in Training (ASIT) The Royal Society of Medicine (RSM)

Starter Grant, awarded by Oxsonics, Oxford (2021) Faculty Research Support Fund grant, University of Surrey (2021) One Year Research Fellowship, Royal College of Surgeons England (2020) Alex Simpson-Smith Travel Award (2017) Moynihan Prize (2017) Hunterian Professorship, Royal College of Surgeons England (2018) Sir James Fraser Travelling Fellowship in General Surgery, Royal College of Surgeons Edinburgh (2017)

• Sarah Blacker, Rajiv P. Lahiri, Mary Phillips, Graham Pinn, Tim D. Pencavel, Rajesh Kumar, Angela T. Riga, Tim R. Worthington, Nariman D. Karanjia, Adam E. Frampton. Which patients benefit from preoperative biliary drainage in resectable pancreatic cancer? Expert Review of Gastroenterology & Hepatology. DOI: 10.1080/17474124.2021.1915127 • Frilling A, Clift AK, Frampton AE, Bomanji J, Kaemmerer D, Al-Nahhas A, Alsafi A, Kidd M, Modlin IM, Hoersch D, Baum RP. A combination of surgery, theranos